Replies to post #189495 on Amarin Corp Plc (AMRN)

[KCSVEN]

That's a good point, hard to find comparisons to this situation. Investors on these boards are all close to this and talk to people about it, seems everyone is aware of Vascepa, but the reality is the vast majority of people have no idea what it is. I randomly asked 20 people at work, not one knew what it was. I know small sample size and all but mainstream knowledge of Vascepa is low.


But also is the catch 22, once they get expanded label will need high cost marketing and sales blitz. Once date of FDA approval is mostly known, if GIA, they should be hiring more sales people months before approval.


Since no company has really gone through this exact situation very hard to judge what management should be accomplishing at this point in time.

If it does stay range bound here for the next 7 months with similar up and down volatility I can knock 7 bucks off my basis selling options so something to be hopeful for if a real long haul here.

[jessellivermore]

jt

Quote: "short term expectations are too high, long term expectations too low."

Exactly...You can't make bricks without straw...Granted the Q1 CC was a total yawn...But understand the reason it was such a total yawn was because we have so much to look forward to in terms of catalysts and here we are waiting for the race to begin...

Keep it in your pants...BPs can not shoot fireballs out their asses regardless of what any of you think...In fact BPs don't really do much of the heavy lifting...Rather they just have more money and their general strategy is bailing out smaller companies that run into cash short falls because of the exhausting long term process of getting an FDA label..

At present Amarin is not in the situation where it is so cash strapped it must sell cheap...We are closer than you think and Vascepa could be one of the all time winners...and why give it up to a BP that has contributed nothing to Vascepa's development...Because you are in a hurry...

The conference was not about AMRN not filing an sNDA...It was just it is going to take a few months to get the label...

The conference was not about AMRN not increasing scrips..Its just we still have a ways to go...

The conference was not about how different medical societies had expressed a high level of skepticism about Vascepa...

The conference was not about AMRN being in financial straights with no current source of income...

How about we look on some of the good things ...

":>)